Meenu Chhabra joined Allozyne as President and Chief Executive Officer in October 2007. Prior to joining the Allozyne team, Ms. Chhabra was Vice President Business Development and Licensing for Novartis in Switzerland. Immediately prior to joining Novartis, Ms Chhabra served as the Chief Business Officer at BioXell SpA in Italy. Ms. Chhabra also has held management positions at NeurAxon, Inc. and Fresenius Kabi AG, as well as sales and marketing roles at Parke Davis/Warner Lambert, Inc. and Bristol-Myers Squibb, Inc. Ms. Chhabra obtained her Hons B.Sc. degree from the University of Toronto in Pharmacology and her Masters Business Administration from the Schulich School of Business at York University.